• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于活细菌的免疫-光动力疗法:丁酸梭菌的代谢标记用于根除恶性黑色素瘤。

Living Bacteria-Based Immuno-Photodynamic Therapy: Metabolic Labeling of Clostridium butyricum for Eradicating Malignant Melanoma.

机构信息

Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore, 117585, Singapore.

The Eighth Affiliated Hospital, Sun Yat-Sen University, 3025 Shennan Middle Road, Shenzhen, 518033, China.

出版信息

Adv Sci (Weinh). 2022 May;9(14):e2105807. doi: 10.1002/advs.202105807. Epub 2022 Mar 11.

DOI:10.1002/advs.202105807
PMID:35277932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9108598/
Abstract

Due to the complexity, aggressiveness, and heterogeneity of malignant melanoma, it is difficult to eradicate the whole tumor through conventional treatment. Herein, a strategy of metabolic engineering labeled anaerobic oncolytic bacteria (Clostridium butyricum) is demonstrated to achieve the ablation of melanoma. In this system, the metabolic substrate of C. butyricum d-alanine (d-Ala) is first conjugated with a photosensitizer (TPApy) showing aggregation-induced emission (AIE). The yielded metabolic substrate of d-Ala-TPAPy can be metabolically incorporated into bacterial peptidoglycan to form engineered C. Butyricum. Once the engineered C. butyricum is injected into melanoma, the bacteria can only proliferate in an anaerobic zone, stimulate the tumor immune microenvironment, and ablate the tumor hypoxia region. Following that, the relatively rich oxygen content in the peripheral area can induce the death of C. butyricum. The photosensitizer (PS) on the bacteria can subsequently exert a photodynamic effect in the oxygen-rich region and further remove the melanoma residue under light irradiation. Prominent in vivo melanoma ablation results revealed that the engineering oncolytic bacteria can provide a promising regime for solid tumor eradication.

摘要

由于恶性黑色素瘤的复杂性、侵袭性和异质性,通过常规治疗很难彻底根除整个肿瘤。在此,我们展示了一种代谢工程标记的厌氧溶瘤菌(丁酸梭菌)策略,以实现黑色素瘤的消融。在该系统中,丁酸梭菌的代谢底物 D-丙氨酸(d-Ala)首先与表现出聚集诱导发射(AIE)的光敏剂(TPApy)缀合。生成的 d-Ala-TPAPy 代谢底物可以代谢掺入细菌肽聚糖中,形成工程化的丁酸梭菌。一旦将工程化的丁酸梭菌注入黑色素瘤中,细菌只能在厌氧区中增殖,刺激肿瘤免疫微环境并消融肿瘤缺氧区域。随后,周围区域相对丰富的氧气含量会导致丁酸梭菌死亡。细菌上的光敏剂(PS)随后可以在富含氧气的区域中发挥光动力作用,并在光照下进一步去除黑色素瘤残留。突出的体内黑色素瘤消融结果表明,工程溶瘤菌可为实体瘤的根除提供一种有前景的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/41ac47b0b930/ADVS-9-2105807-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/a39d0e9f83e9/ADVS-9-2105807-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/d4e2fc237dbc/ADVS-9-2105807-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/dbee340b3d16/ADVS-9-2105807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/9c88164b1762/ADVS-9-2105807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/6e513aae0028/ADVS-9-2105807-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/41ac47b0b930/ADVS-9-2105807-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/a39d0e9f83e9/ADVS-9-2105807-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/d4e2fc237dbc/ADVS-9-2105807-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/dbee340b3d16/ADVS-9-2105807-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/9c88164b1762/ADVS-9-2105807-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/6e513aae0028/ADVS-9-2105807-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37c1/9108598/41ac47b0b930/ADVS-9-2105807-g006.jpg

相似文献

1
Living Bacteria-Based Immuno-Photodynamic Therapy: Metabolic Labeling of Clostridium butyricum for Eradicating Malignant Melanoma.基于活细菌的免疫-光动力疗法:丁酸梭菌的代谢标记用于根除恶性黑色素瘤。
Adv Sci (Weinh). 2022 May;9(14):e2105807. doi: 10.1002/advs.202105807. Epub 2022 Mar 11.
2
Cell factories converting lactate and acetate to butyrate: Clostridium butyricum and microbial communities from dark fermentation bioreactors.将乳酸和乙酸转化为丁酸的细胞工厂:丁酸梭菌和黑暗发酵生物反应器中的微生物群落。
Microb Cell Fact. 2019 Feb 13;18(1):36. doi: 10.1186/s12934-019-1085-1.
3
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.丁酸梭菌是一种产生丁酸的益生菌,通过调节 Wnt 信号通路和肠道微生物群来抑制肠道肿瘤的发展。
Cancer Lett. 2020 Jan 28;469:456-467. doi: 10.1016/j.canlet.2019.11.019. Epub 2019 Nov 14.
4
Visualization and In Situ Ablation of Intracellular Bacterial Pathogens through Metabolic Labeling.通过代谢标记可视化和原位消融细胞内细菌病原体。
Angew Chem Int Ed Engl. 2020 Jun 8;59(24):9288-9292. doi: 10.1002/anie.201910187. Epub 2019 Sep 18.
5
Biotechnological potential of Clostridium butyricum bacteria.丁酸梭菌的生物技术潜力。
Braz J Microbiol. 2014 Oct 9;45(3):892-901. doi: 10.1590/s1517-83822014000300019. eCollection 2014.
6
Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy.代谢工程细菌作为光控活体治疗剂用于抗血管生成肿瘤治疗。
Mater Horiz. 2021 May 1;8(5):1454-1460. doi: 10.1039/d0mh01582b. Epub 2021 Mar 4.
7
Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.通过肿瘤微环境调控工程化光敏剂纳米平台用于放大光动力免疫治疗。
Nanoscale Horiz. 2021 Feb 1;6(2):120-131. doi: 10.1039/d0nh00480d. Epub 2020 Nov 18.
8
Analysis of the core genome and pangenome of .分析. 的核心基因组和泛基因组。
Genome. 2021 Jan;64(1):51-61. doi: 10.1139/gen-2020-0072. Epub 2020 Oct 26.
9
Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy.聚集诱导发光光敏剂工程化抗癌纳米医学用于协同化学/化学动力/光动力治疗。
Adv Healthc Mater. 2024 Apr;13(11):e2303643. doi: 10.1002/adhm.202303643. Epub 2023 Dec 25.
10
Hydrogen production from glucose by anaerobes.厌氧菌利用葡萄糖产氢。
Biotechnol Prog. 2005 Nov-Dec;21(6):1786-8. doi: 10.1021/bp050224r.

引用本文的文献

1
Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies.合成生物学技术的再合成:将工程菌与其他抗肿瘤疗法相结合。
Front Microbiol. 2025 Jul 28;16:1545334. doi: 10.3389/fmicb.2025.1545334. eCollection 2025.
2
Modified probiotics and the related combinatorial therapeutics.改良益生菌及相关联合疗法。
Acta Pharm Sin B. 2025 May;15(5):2431-2453. doi: 10.1016/j.apsb.2025.03.021. Epub 2025 Mar 14.
3
Illuminating Hope for Tumors: The Progress of Light-Activated Nanomaterials in Skin Cancer.

本文引用的文献

1
Aptamer-assisted tumor localization of bacteria for enhanced biotherapy.适配体辅助细菌肿瘤定位增强生物治疗。
Nat Commun. 2021 Nov 15;12(1):6584. doi: 10.1038/s41467-021-26956-8.
2
An Enzyme-Activatable Aggregation-Induced-Emission Probe: Intraoperative Pathological Fluorescent Diagnosis of Pancreatic Cancer via Specific Cathepsin E.一种酶激活的聚集诱导发光探针:通过特异性组织蛋白酶E实现胰腺癌术中病理荧光诊断
Adv Mater. 2022 Jan;34(3):e2107444. doi: 10.1002/adma.202107444. Epub 2021 Nov 27.
3
Trapping endoplasmic reticulum with amphiphilic AIE-active sensor via specific interaction of ATP-sensitive potassium (K).
照亮肿瘤的希望:光激活纳米材料在皮肤癌治疗中的进展
Int J Nanomedicine. 2025 Apr 18;20:5081-5118. doi: 10.2147/IJN.S506000. eCollection 2025.
4
Challenges and New Directions in Therapeutic Cancer Vaccine Development.治疗性癌症疫苗开发中的挑战与新方向
Vaccines (Basel). 2024 Nov 28;12(12):1341. doi: 10.3390/vaccines12121341.
5
Colon-specific controlled release of oral liposomes for enhanced chemo-immunotherapy against colorectal cancer.用于增强结直肠癌化学免疫治疗的口服脂质体结肠特异性控释
Acta Pharm Sin B. 2024 Nov;14(11):4977-4993. doi: 10.1016/j.apsb.2024.09.015. Epub 2024 Sep 20.
6
Bioinspired micro- and nanostructured systems for cancer therapy.用于癌症治疗的仿生微纳结构系统
MedComm (2020). 2024 Nov 28;5(12):e70025. doi: 10.1002/mco2.70025. eCollection 2024 Dec.
7
Bacterial live therapeutics for human diseases.用于人类疾病的细菌活体疗法。
Mol Syst Biol. 2024 Dec;20(12):1261-1281. doi: 10.1038/s44320-024-00067-0. Epub 2024 Oct 23.
8
Towards overcoming obstacles of type II photodynamic therapy: Endogenous production of light, photosensitizer, and oxygen.迈向克服II型光动力疗法的障碍:光、光敏剂和氧气的内源性产生。
Acta Pharm Sin B. 2024 Mar;14(3):1111-1131. doi: 10.1016/j.apsb.2023.11.007. Epub 2023 Nov 4.
9
Recent advances in single-cell engineered live biotherapeutic products research for skin repair and disease treatment.单细胞工程化活体生物治疗产品在皮肤修复和疾病治疗方面的研究进展。
NPJ Biofilms Microbiomes. 2023 Dec 8;9(1):95. doi: 10.1038/s41522-023-00463-8.
10
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.基于细菌的癌症免疫疗法:临床前研究的系统评价。
Front Immunol. 2023 Aug 3;14:1140463. doi: 10.3389/fimmu.2023.1140463. eCollection 2023.
通过三磷酸腺苷敏感钾离子(K)的特异性相互作用,用两亲性聚集诱导发光活性传感器捕获内质网。
Natl Sci Rev. 2020 Aug 31;8(6):nwaa198. doi: 10.1093/nsr/nwaa198. eCollection 2021 Jun.
4
Customized materials-assisted microorganisms in tumor therapeutics.定制材料辅助微生物在肿瘤治疗中的应用。
Chem Soc Rev. 2021 Nov 15;50(22):12576-12615. doi: 10.1039/d0cs01571g.
5
Both-In-One Hybrid Bacteria Suppress the Tumor Metastasis and Relapse via Tandem-Amplifying Reactive Oxygen Species-Immunity Responses.双效合一的杂交细菌通过串联放大的活性氧免疫反应抑制肿瘤转移和复发。
Adv Healthc Mater. 2021 Nov;10(21):e2100950. doi: 10.1002/adhm.202100950. Epub 2021 Sep 20.
6
Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery.基于细菌的癌症治疗:一种新兴的靶向药物/基因传递工具盒。
Biomaterials. 2021 Oct;277:121124. doi: 10.1016/j.biomaterials.2021.121124. Epub 2021 Sep 10.
7
Tumor Temporal Proteome Profiling Reveals the Immunological Triple Offensive Induced by Synthetic Anti-Cancer .肿瘤时间蛋白质组谱分析揭示了合成抗癌药物诱导的免疫三重攻击。
Front Immunol. 2021 Aug 19;12:712936. doi: 10.3389/fimmu.2021.712936. eCollection 2021.
8
Bacteria and Archaea: A new era of cancer therapy.细菌和古菌:癌症治疗的新时代。
J Control Release. 2021 Oct 10;338:1-7. doi: 10.1016/j.jconrel.2021.08.019. Epub 2021 Aug 12.
9
Decorating Bacteria with a Therapeutic Nanocoating for Synergistically Enhanced Biotherapy.用治疗性纳米涂层修饰细菌以协同增强生物疗法
Small. 2021 Sep;17(37):e2101810. doi: 10.1002/smll.202101810. Epub 2021 Aug 8.
10
Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft.纳米抗体修饰的高性能 AIE 光敏剂纳米颗粒用于精准光动力学治疗患者来源的肿瘤异种移植的口腔癌。
Biomaterials. 2021 Jul;274:120870. doi: 10.1016/j.biomaterials.2021.120870. Epub 2021 May 11.